Australia's first medical research institute to use TIBCO Spotfire
Australia's first medical research institute to use TIBCO Spotfire
Thumbnail:
Today, life sciences organizations such as WEHI face significant pressure to quickly identify and test potential novel drug therapies. To identify these molecule candidates, WEHI scientists test a bank of more than 350,000 compounds on a daily basis. With TIBCO Spotfire's interactive and visual interface, WEHI researchers will be able to quickly and easily spot trends, outliers, and errors in large data volumes of molecular compounds in assay results, and explore real-time hypotheses in various conditions.

















